Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

Conditions:   Tuberculosis;   Hiv Intervention:   Drug: Dolutegravir 50 MG Sponsors:   University of KwaZulu;   Centre for the AIDS Programme of Research in South Africa Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials